180 related articles for article (PubMed ID: 19189276)
1. The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.
McDuff FO; Naud JF; Montagne M; Sauvé S; Lavigne P
J Mol Recognit; 2009; 22(4):261-9. PubMed ID: 19189276
[TBL] [Abstract][Full Text] [Related]
2. New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.
Beaulieu ME; McDuff FO; Frappier V; Montagne M; Naud JF; Lavigne P
J Mol Recognit; 2012 Jul; 25(7):414-26. PubMed ID: 22733550
[TBL] [Abstract][Full Text] [Related]
3. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of discrimination between cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors.
Sauvé S; Naud JF; Lavigne P
J Mol Biol; 2007 Jan; 365(4):1163-75. PubMed ID: 17109882
[TBL] [Abstract][Full Text] [Related]
5. Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter.
Lebel R; McDuff FO; Lavigne P; Grandbois M
Biochemistry; 2007 Sep; 46(36):10279-86. PubMed ID: 17705400
[TBL] [Abstract][Full Text] [Related]
6. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamics of b-HLH-LZ protein binding to DNA: the energetic importance of protein-DNA contacts in site-specific E-box recognition by the complete gene product of the Max p21 transcription factor.
Meier-Andrejszki L; Bjelić S; Naud JF; Lavigne P; Jelesarov I
Biochemistry; 2007 Oct; 46(43):12427-40. PubMed ID: 17915948
[TBL] [Abstract][Full Text] [Related]
8. Toward the elucidation of the structural determinants responsible for the molecular recognition between Mad1 and Max.
Montagne M; Naud JF; McDuff FO; Lavigne P
Biochemistry; 2005 Sep; 44(38):12860-9. PubMed ID: 16171401
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of the structural determinants responsible for the specific formation of heterodimeric Mxd1/Max b-HLH-LZ and its binding to E-box sequences.
Montagne M; Naud JF; Lavigne P
J Mol Biol; 2008 Feb; 376(1):141-52. PubMed ID: 18155722
[TBL] [Abstract][Full Text] [Related]
10. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
[TBL] [Abstract][Full Text] [Related]
11. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
Davis LJ; Halazonetis TD
Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
[TBL] [Abstract][Full Text] [Related]
14. Methods for the expression, purification, preparation, and biophysical characterization of constructs of the c-Myc and Max b-HLH-LZs.
Beaulieu ME; McDuff FO; Bédard M; Montagne M; Lavigne P
Methods Mol Biol; 2013; 1012():7-20. PubMed ID: 24006055
[TBL] [Abstract][Full Text] [Related]
15. DNA binding by N- and L-Myc proteins.
Ma A; Moroy T; Collum R; Weintraub H; Alt FW; Blackwell TK
Oncogene; 1993 Apr; 8(4):1093-8. PubMed ID: 8455937
[TBL] [Abstract][Full Text] [Related]
16. Miz-1 and Max compete to engage c-Myc: implication for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1.
Bédard M; Maltais L; Montagne M; Lavigne P
Proteins; 2017 Feb; 85(2):199-206. PubMed ID: 27859590
[TBL] [Abstract][Full Text] [Related]
17. c-Myc does not require max for transcriptional activity in PC-12 cells.
Ribon V; Leff T; Saltiel AR
Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
[TBL] [Abstract][Full Text] [Related]
18. Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.
Crouch DH; Fisher F; La Rocca SA; Goding CR; Gillespie DA
Nucleic Acids Res; 2005; 33(16):5235-42. PubMed ID: 16166655
[TBL] [Abstract][Full Text] [Related]
19. Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.
Maltais L; Montagne M; Bédard M; Tremblay C; Soucek L; Lavigne P
PLoS One; 2017; 12(3):e0174413. PubMed ID: 28350847
[TBL] [Abstract][Full Text] [Related]
20. Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.
D'Agnano I; Valentini A; Gatti G; Chersi A; Felsani A
J Cell Physiol; 2007 Jan; 210(1):72-80. PubMed ID: 16998799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]